Marjo
Marjo Ali-Äijälä, Latvatie FI
Patent application number | Description | Published |
---|---|---|
20110162656 | INSERTER - The invention relates to an inserter for an intrauterine system, comprising a handle ( | 07-07-2011 |
Marjo Elorae, Tampere FI
Patent application number | Description | Published |
---|---|---|
20090181136 | Method for Sealing a Package and a Package - The invention relates to a method for sealing a package ( | 07-16-2009 |
20090298662 | Method for protecting the untrimmed edge of a paperboard or paper - The invention relates to a method for protecting the untrimmed edge of paperboard or paper ( | 12-03-2009 |
Marjo Kruts, Appeltern NL
Patent application number | Description | Published |
---|---|---|
20080207446 | Use of Phenylsemicarbazones for Seed Treatment - The invention relates to the use of phenylsemicarbazones of formula (I); wherein R | 08-28-2008 |
Marjo Määttänen, Espoo FI
Patent application number | Description | Published |
---|---|---|
20150225901 | Method of producing dissolving pulp, dissolving pulp and use of method - A method of producing dissolving pulp from a recycled fibrous feedstock. The method comprises providing a fibrous material comprising cellulose, lignin and hemicellulose, said fibre source further having a lignin content of 0.1 to 7% lignin and an ash content of up to 3%; subjecting the fibrous material to an alkaline extraction at a temperature of about 0 to 25° C., to produce fibres having a reduced content of hemicellulose; subjecting the fibres thus obtained to a bleaching treatment carried out with oxidative chemical reagents in order to reduce the lignin content of the fibres; and recovering the fibres thus obtained. By means of the method, dissolving pulp can be produced from recycled paper and cardboard products. | 08-13-2015 |
Marjo Merslavic, Novem Mestu SI
Patent application number | Description | Published |
---|---|---|
20100298400 | SALTS OF PERINDOPRIL - The present invention relates to new salts of perindopril, particularly to a new calcium salt and new amine salts of perindopril, to a process for their preparation and to a pharmaceutical formulations containing the new salts. | 11-25-2010 |
Marjo Pihlavisto, Kaarina FI
Patent application number | Description | Published |
---|---|---|
20080197641 | Dynamically Self-Locking Catching Device - The invention concerns a catching device ( | 08-21-2008 |
20080255169 | Sulphonamide Derivatives - The invention relates to sulphonamide derivatives of formula (I), | 10-16-2008 |
20090023735 | Sulphonamide Derivatives - The invention relates to sulphonamide derivatives of formula (I), where R | 01-22-2009 |
20110021760 | CRYSTALLINE VAP-1 AND USES THEREOF - The present invention relates to crystalline vascular adhesion protein-1 (VAP-1) and in particular to methods for the use of structural information of crystalline human VAP-1 for ligand and/or inhibitor identification, design and production, as well as screening assays for detections of same. The invention further relates to inhibitors identified by the assays according to the present invention. | 01-27-2011 |
20110263567 | COMPOUNDS FOR INHIBITING SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) / VASCULAR ADHESION PROTEIN-1 (VAP-1) AND USES THEREOF FOR TREATMENT AND PREVENTION OF DISEASES - The present invention relates to compounds of general formula (i) having an oxime moiety or a pharmaceutically acceptable salt, hydrate or solvate thereof and its use for inhibiting semicarbazide-sensitive amine oxidase (SSAO), also known as vascular adhesion protein-1 (VAP-1), a pharmaceutical composition comprising the compound or a salt, hydrate or solvate thereof as an active ingredient, a method for the prevention or the treatment of a SSAO/VAP-1 related disease, said diseases including acute or chronic inflammatory diseases, diseases related to carbohydrate metabolism, diabetes-associated complications, diabetic retinopathy and macular oedema, diseases related to adipocyte or smooth muscle dysfunctions, neurodegenerative diseases and vascular diseases. | 10-27-2011 |
20120196884 | UREA SUBSTITUTED SULPHONAMIDE DERIVATIVES - The present invention relates to sulphonamide derivatives, whith a urea moiety. The invention also relates to the use of the derivatives as inhibitors of collagen receptor integrins, especially α2β1 integrin inhibitors e.g. in connection with diseases and medical conditions that involve the action of cells and platelets expressing collagen receptors, their use as a medicament, e.g. for the treatment of thrombosis, inflammation, cancer and vascular diseases, pharmaceutical compositions containing them and a process for preparing them. The sulphonamide derivatives have the general formula (I) or (I′). | 08-02-2012 |
20130195883 | USE OF VAP-1 INHIBITORS FOR TREATING FIBROTIC CONDITIONS - The present invention relates to inhibitors of VAP-1 and their use as medicaments in treating fibrotic conditions. Furthermore, the present invention relates to a method of diagnosing a fibrotic condition on the basis of elevated level of soluble VAP-1 or SSAO activity in a bodily fluid, and to a kit for use in said diagnostic method. | 08-01-2013 |
20140024648 | NEW PYRIDAZINONE AND PYRIDONE COMPOUNDS - The invention relates to pyridazinone and pyridone compounds having formula (I) or (I′), and pharmaceutically acceptable salts, hydrates, and solvates thereof (I) wherein R | 01-23-2014 |
Marjo Yliperttula, Espoo FI
Patent application number | Description | Published |
---|---|---|
20130344036 | PLANT DERIVED CELL CULTURE MATERIAL - The present invention relates material that is useful in culturing and transferring cells as well as delivering cells. The material comprises plant derived cellulose nanofibers or derivatives thereof, wherein the cellulose nanofibers are in a form of a hydrogel or membrane. The invention also provides methods for producing these materials and compositions and uses thereof. | 12-26-2013 |
20140010790 | CELL CULTURE MATERIAL BASED ON MICROBIAL CELLULOSE - The present invention relates material based on microbial cellulose that is useful in culturing and transferring cells as well as delivering drugs. The material comprises cellulose nanofibers and/or derivatives thereof, based on microbial cellulose, wherein the cellulose nanofibers are in a form of a hydrogel or membrane. The invention also provides methods for producing these materials and compositions and uses thereof. | 01-09-2014 |
Marjo Ylipertula, Espoo FI
Patent application number | Description | Published |
---|---|---|
20130330379 | DRUG DELIVERY COMPOSITIONS - The present invention relates material that is useful in drug delivery compositions. The material comprises cellulose nanofibers and/or derivatives thereof, wherein the cellulose nanofibers are in a form of a hydrogel or membrane. The invention also provides methods for producing these materials and compositions and uses thereof. | 12-12-2013 |